D.A. Davidson & Co’s Natus Medical Inc NTUS Stock Holding History

D.A. Davidson & Co’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-47	Closed	-$1K	–	2464
2017 Q1	$1K	Sell	47 -5,785	-99%	-$217K	﹤0.01%	2312
2016 Q4	$202K	Buy	5,832 +626	+12%	+$24.6K	﹤0.01%	997
2016 Q3	$203K	Buy	5,206 +165	+3%	+$6.58K	0.01%	942
2016 Q2	$189K	Buy	5,041 +2,413	+92%	+$80.8K	0.01%	866
2016 Q1	$100K	Buy	2,628 +2,375	+939%	+$88.4K	﹤0.01%	1131
2015 Q4	$12K	Hold	253	–	–	﹤0.01%	1872
2015 Q3	$9K	Buy	253 +69	+38%	+$2.93K	﹤0.01%	1888
2015 Q2	$7K	Buy	184 +84	+84%	+$3.35K	﹤0.01%	1961
2015 Q1	$3K	Hold	100	–	–	﹤0.01%	1976
2014 Q4	$3K	Hold	100	–	–	﹤0.01%	2000
2014 Q3	$2K	Hold	100	–	–	﹤0.01%	2047
2014 Q2	$2K	Hold	100	–	–	﹤0.01%	2045
2014 Q1	$2K	Hold	100	–	–	﹤0.01%	2042
2013 Q4	$2K	Hold	100	–	–	﹤0.01%	1981
2013 Q3	$1K	Hold	100	–	–	﹤0.01%	1708
2013 Q2	$1K	Buy	+100	New	+$1.36K	﹤0.01%	1663

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

D.A. Davidson & Co's NTUS Position: Q2 2017 in Review

D.A. Davidson & Co sold out of Natus Medical Inc (NTUS) in Q2 2017, closing a stake of 47 shares — an estimated $1K sold.

D.A. Davidson & Co first reported a position in NTUS in Q2 2013 and held it in 16 quarters. The position peaked at $203K in Q3 2016. 217 funds tracked by Wall St. Rank hold NTUS as of Q2 2017.

D.A. Davidson & Co reported no remaining Natus Medical Inc position as of Q2 2017 after selling out during the quarter.
D.A. Davidson & Co sold 47 Natus Medical Inc shares in Q2 2017, an estimated $1K.
D.A. Davidson & Co first reported a position in Natus Medical Inc in Q2 2013 and held it in 16 quarters.
D.A. Davidson & Co's Natus Medical Inc position peaked at $203K in Q3 2016.
217 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2017.

Based on D.A. Davidson & Co's 13F filing for Q2 2017, filed 11 Aug 2017.